PCSK9 antagonists

Details for Australian Patent Application No. 2010327924 (hide)

Owner Novartis AG IRM LLC

Inventors Rue, Sarah; Cohen, Steven B.; Li, Jun; Yowe, David

Agent Davies Collison Cave

Pub. Number AU-A-2010327924

PCT Pub. Number WO2011/072263

Priority 61/285,942 11.12.09 US

Filing date 10 December 2010

Wipo publication date 16 June 2011

International Classifications

C07K 16/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 3/06 Drugs for disorders of the metabolism

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/072263 Priority application(s): WO2011/072263

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010327926-Aminoacyl tRNA synthetases for modulating inflammation

2010327923-Inorganic phosphate compositions and methods